Abstract 4365806: <i>Patient and Procedural Characteristics Associated with GERD and Chest Pain After Atrial Fibrillation Ablation with Esophageal Cooling: Results from the Multicenter EVERCOOL AF Registry.</i>

J Joshua Silverstein (Allegheny Health Network, Baden, Pennsylvania, United States) G George Shaw (Allegheny Health Network, Pittsburgh, Pennsylvania, United States) H Huy Phan W William Belden (Allegheny General Hospital, Pittsburgh, Pennsylvania, United States) A Amit Thosani (ALLEGHENY GENERAL HOSPITAL, Pittsburgh, Pennsylvania, United States) E Emerson Liu (ALLEGHENY GENERAL HOSPITAL, Pittsburgh, Pennsylvania, United States) A Alexandru Costea (The Christ Hospital, Cincinatti, Ohio, United States) P Parin Patel (Ascension St Vincent, Indianapolis, Indiana, United States) T Tiffany Sharkoski (Haemonetics, Boston, Massachusetts, United States) Q Qun Sha (Haemonetics, Boston, Massachusetts, United States) E Erik Kulstad (UTSW, Dallas, Texas, United States) S Susan Bezenek (HRCRS, Birmingham, Alabama, United States) A Allyson Varley (HRCRS, Birmingham, Alabama, United States) D David Singh (QUEENS MEDICAL CENTER, Honolulu, Hawaii, United States) M Mark Metzl (Endeavor Health, Glenview , Illinois, United States)

Abstract

Background: Gastroesophageal reflux disease (GERD) and chest pain are common complications following catheter ablation for atrial fibrillation (AF), often attributed to esophageal thermal injury. Active esophageal cooling reduces esophageal temperature and injury risk and has been shown to reduce post-ablation chest pain, yet some patients continue to experience GERD-like symptoms. Factors associated with these complications, despite esophageal cooling, remain unclear. Objective: To identify patient and procedural characteristics associated with post-ablation GERD symptoms and chest pain in AF patients undergoing pulmonary vein isolation with esophageal cooling. Methods: In this multicenter study, patients undergoing left atrial ablation with esophageal cooling for paroxysmal or persistent AF completed a standardized questionnaire post-procedure. GERD symptoms were assessed using the GERD-Q (score ≥8 indicating high probability of GERD) at 7–14 days. Chest pain was queried separately using the same response scale. Associations with demographic and procedural variables were evaluated. Results: Among 295 patients completing post-ablation questionnaires, 44 (14.9%) met criteria for GERD and 71 (24.1%) reported chest pain. GERD symptoms were more common in patients who underwent ablation with lower anterior maximum power (50.0 ± 9.3 W vs. 54.0 ± 14.0 W, p=0.020). No significant associations were observed between GERD symptoms and age, sex, BMI, catheter type, or lesion strategy. In the chest pain analysis, patients reporting post-ablation chest pain were younger (64.5 ± 9.3 vs. 67.5 ± 10.2 years, p=0.026) and had higher mean LVEF (57.1 ± 6.6% vs. 53.1 ± 10.2%, p=0.001). Chest pain was less common among those achieving bilateral first-pass isolation (59.2% vs. 72.6%, p=0.033). No differences were found for catheter type, ablation power, or use of high-power short-duration ablation. Conclusion: In patients undergoing AF ablation with active esophageal cooling, lower anterior ablation power was associated with post-ablation GERD symptoms. Younger age, higher LVEF, and lack of bilateral first-pass isolation were associated with post-ablation chest pain. These findings suggest that despite esophageal protection, both procedural and patient-specific factors may contribute to symptom development.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (15)

J

Joshua Silverstein

Allegheny Health Network, Baden, Pennsylvania, United States

G

George Shaw

Allegheny Health Network, Pittsburgh, Pennsylvania, United States

H

Huy Phan

W

William Belden

Allegheny General Hospital, Pittsburgh, Pennsylvania, United States

A

Amit Thosani

ALLEGHENY GENERAL HOSPITAL, Pittsburgh, Pennsylvania, United States

E

Emerson Liu

ALLEGHENY GENERAL HOSPITAL, Pittsburgh, Pennsylvania, United States

A

Alexandru Costea

The Christ Hospital, Cincinatti, Ohio, United States

P

Parin Patel

Ascension St Vincent, Indianapolis, Indiana, United States

T

Tiffany Sharkoski

Haemonetics, Boston, Massachusetts, United States

Q

Qun Sha

Haemonetics, Boston, Massachusetts, United States

E

Erik Kulstad

UTSW, Dallas, Texas, United States

S

Susan Bezenek

HRCRS, Birmingham, Alabama, United States

A

Allyson Varley

HRCRS, Birmingham, Alabama, United States

D

David Singh

QUEENS MEDICAL CENTER, Honolulu, Hawaii, United States

M

Mark Metzl

Endeavor Health, Glenview , Illinois, United States